Caris Life Sciences (CAI) Interest Expenses (2024 - 2026)

Caris Life Sciences' Interest Expenses history runs 3 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• In Q1 2026, Interest Expenses changed 0.21% year-over-year to $12.8 million; the TTM figure through Mar 2026 stood at $50.2 million (down 6.18% YoY), while the FY2025 annual figure was $410.4 million, down 2.65% from the prior year.
• Interest Expenses for Q1 2026 stood at $12.8 million, up from $11.4 million in the prior quarter.
• The five-year high for Interest Expenses was $450.5 million in Q3 2025, with the low at $11.4 million in Q4 2025.
• The 3-year median for Interest Expenses is $13.5 million (2024), against an average of $109.6 million.
• Peak annual rise in Interest Expenses reached 3164.46% in 2025, while the deepest fall reached 14.37% in 2025.
• Caris Life Sciences' Interest Expenses stood at $13.3 million in 2024, then dropped by 14.37% to $11.4 million in 2025, then gained by 12.79% to $12.8 million in 2026.
• Business Quant data shows CAI's Interest Expenses at $12.8 million in Q1 2026, $11.4 million in Q4 2025, and $450.5 million in Q3 2025.